SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-002992
Filing Date
2021-01-11
Accepted
2021-01-11 17:16:53
Documents
2
Period of Report
2021-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1601
2 POA DOCUMENT poa.txt EX-24.3_955370 3607
  Complete submission text file 0001209191-21-002992.txt   6610
Mailing Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120 33(0)155427878
DBV Technologies S.A. (Issuer) CIK: 0001613780 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O DBV TECHNOLOGIES S.A. 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address
Ferrere Mailys (Reporting) CIK: 0001838244 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36697 | Film No.: 21521608